Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px
Document › Details

MorphoSys AG. (3/9/17). "Press Release: MorphoSys AG Presents Strong Results for Fiscal Year 2016". Planegg-Martinsried.

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Organisation 2 Janssen (Group)
  Group Johnson & Johnson (JnJ) (Group)
Products Product guselkumab (CNTO1959)
  Product 2 tafasitamab (MOR208 / XmAb5574)
Persons Person Moroney, Simon E. (MorphoSys 1992–201908 CEO + Founder STEPPED DOWN 9/19)
  Person 2 Holstein, Jens (BioNTech 202107– CFO before MorphoSys 201105–202012 CFO before Fresenius Kabi)
     


   
Record changed: 2023-06-05

Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

More documents for MorphoSys (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x300px




» top